Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 10
Original Research
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,167 | Dovepress* | 10,325+ | 2,201 | 12,526 | |
| PubMed Central* | 842 | 401 | 1,243 | ||
| Totals | 11,167 | 2,602 | 13,769 | ||
| *Since 27 January 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar